Bristol-Myers Squibb stock heads into the open after a 3.2% drop
Published on 09/09/2026 at 06:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bristol-Myers Squibb stock closed at USD 66.82 on the NYSE on September 4, 2026, recording a 3.2 percent decline for the session. The shares moved within a daily range between USD 67.72 at the high and USD 66.58 at the low, with reported volume of 4,825,447 shares, according to price data compiled from the exchange history at Forbes data. Compared with its previous close near USD 69.04 earlier in the week, the move left the stock several dollars below that level and added to recent volatility.
September 4, 2026 in numbers
Bristol-Myers Squibb Co. (ISIN US1078421011, NYSE: BMY) showed a clear pullback in the last completed session, as the USD 66.82 close on September 4, 2026, marked a loss of roughly USD 2.22 from the prior day, equivalent to a 3.2 percent slide based on the historical table provided by Forbes data. During that trading day the share price touched an intraday high of USD 67.72 and a low of USD 66.58, keeping the close within the established range. The reported turnover of 4,825,447 shares indicated moderate activity relative to earlier sessions that week. Against the S&P 500, which eased modestly in the same period according to a broad market wrap from Post-Gazette market coverage, Bristol-Myers Squibb underperformed by several percentage points, underscoring stock-specific selling pressure rather than a purely index-driven move.
External analysis highlighted that this recent decline left Bristol-Myers Squibb trading near the mid point of its longer term range, with commentary at GuruFocus noting a price of USD 64.69 on September 8, 2026, roughly 14.4 percent above one valuation benchmark used in that report. While that later quotation does not belong to the last completed session, it illustrates that the stock has recently been fluctuating within a band of the mid USD 60s to high USD 60s, following prior sessions where closes around USD 66.81 to USD 68.09 were recorded in late August and early September 2026 in the same historical table at Forbes data. This context suggests that the 3.2 percent move on September 4, 2026, was notable in size compared with the smaller day to day changes earlier in the period, though still within the existing multi week trading corridor.
Today’s drivers to watch
Today, September 9, 2026, Bristol-Myers Squibb does not have a confirmed quarterly earnings release or annual meeting scheduled within the next few trading days in the calendars referenced by earlier coverage at ad hoc summary of external calendars, so near term attention for the stock is likely to remain on sector and macro developments. Broader health care and pharmaceutical sentiment can be influenced by peer news, regulatory decisions, and updates on drug trials across the industry, and these factors may feed into trading in Bristol-Myers Squibb today even without a company specific event on the docket. In addition, the next major macroeconomic releases and any shifts in interest rate expectations could affect defensive and dividend oriented stocks such as large pharmaceutical names, providing a backdrop for how Bristol-Myers Squibb shares trade into today’s US session.
